LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2022

Jun 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2022-05-31

Reporting Person: Diradoorian Raymond H (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-31	Restricted Stock Unit	$	A	9474	Acquired		Common Stock (9474.0)	Direct

Footnotes

F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.